Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen.

Source:http://linkedlifedata.com/resource/pubmed/id/15479440

Download in:

View as

General Info

PMID
15479440